Sep 09, 2021 / 08:15PM GMT
Andrew Christopher Ranieri - Morgan Stanley, Research Division - Equity Analyst
Thank you everyone for joining us today. I'm Drew Ranieri, a medical device analyst here at Morgan Stanley. It's my pleasure to have Micah Young, the CFO of Masimo Corporation, along with Eli Kammerman, Head of Investor Relations. So before we jump into Q&A, I just have to get this disclaimer out of the way first.
For important disclosures, please see morganstanley.com/researchdisclosures. If you have any questions, please reach out to your Morgan Stanley sales rep. So Micah, Eli, thanks for joining us today. Micah, I'm going to hand it over to you for a brief overview of Masimo and then we'll jump into Q&A. So the floor is all yours.
Micah Young - Masimo Corporation - Executive VP of Finance & CFO
Absolutely. Thanks, Drew. Yes. So coming into this year, I think COVID brought a lot of uncertainties around the pace that we would see hospital census and patient volumes recover throughout the year. And as you know, our sensors track very closely with hospital census
Masimo Corp at Morgan Stanley Global Healthcare Conference (Virtual) Transcript
Sep 10, 2021
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers